Safety evaluation of chronic fluconazole therapy

Chemotherapy

Volumn 43, Issue 5, 1997, Pages 371-377

  Stevens, D A ^{a,b,c,d,e,f,g,h}   Diaz, M ^{a,b,c,d,e,f,g,h}   Negroni, R ^{a,b,c,d,e,f,g,h}   Montero Gei, F ^{a,b,c,d,e,f,g,h}   Castro, L G M ^{a,b,c,d,e,f,g,h}   Sampaio, S A P ^{a,b,c,d,e,f,g,h}   Borelli, D ^{a,b,c,d,e,f,g,h}   Restrepo, A ^{a,b,c,d,e,f,g,h}   Franco, L ^{a,b,c,d,e,f,g,h}   Bran, J L ^{a,b,c,d,e,f,g,h}   Arathoon, E G ^{a,b,c,d,e,f,g,h}   Belda, W ⁱ   Cuce, L C ⁱ   Denning, D W ⁱ   Fasano, C ⁱ   Gibbs, D L ⁱ   Gomez, I ⁱ   Taborda, A ⁱ   Tucker, R M ⁱ  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d Hospital San Juan de Dios   (United States)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^g Hospital Pablo Tobon Uribe   (United States)

^h UNIVERSIDAD DE SAN CARLOS DE GUATEMALA   (Guatemala)

ⁱ NONE

Author keywords

Fluconazole; Invasive mycoses; Toxicology

Indexed keywords

ASPARTATE AMINOTRANSFERASE; FLUCONAZOLE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANOREXIA; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG SAFETY; DRUG TOLERABILITY; ENCEPHALITIS; EOSINOPHILIA; FATIGUE; FEMALE; FEVER; GASTRITIS; HAIR LOSS; HEADACHE; HEART INFARCTION; HUMAN; IMPOTENCE; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; MYCOSIS; NAUSEA; PAIN; POLYDIPSIA; PREMATURE EJACULATION; PRIORITY JOURNAL; PRURITUS; TINNITUS; TREMOR; VERTIGO; VISUAL IMPAIRMENT; VOMITING; WEIGHT REDUCTION;

EID: 0030790537     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239592     Document Type: Article

References (8)

1. Bennett J, Grant S (eds): Fluconazole: An Overview. Longhorne. ADIS Press, 1990.
2. Diaz M, Negroni R, Montcro-Gei F, Castro LGM, Sampaio SAP, Borelli D, Restrepo A, Franco L, Bran JL, Arathoon EG, Stevens DA: A Pan-american five year study of fluconazole therapy of deep mycoses in the noncompromised host. Clin Infect Dis 1992;14(suppl 1):S68-S76.
3. Catanzaro A, Galgiani JN, Levine BE, Sharkey-Mathis PK, Fierer J, Stevens DA, Chapman SW, Cloud G, the NIAID Mycoses Study Group: Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. Am J Med 1995;98: 249-256.
4. Anaissie EJ, Kontoyiannis DP, Huls C, Vartivarian SE, Karl C, Prince RA, Bosso J, Bodey GP: Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. J Infect Dis 1995; 172:599-602.
5. Tucker RM, Haq Y, Denning DW, Stevens DA: Adverse events associated with itraconazole in 189 patients on chronic therapy. J Antimi-crob Chemothcr 1990;26:561-566.
6. National Institute of Allergy and Infectious Diseases Mycoses Study Group: Treatment of blastomycosis and histoplasmosis with ketocona zole: Results of a prospective randomized clinical trial. Ann Intern Med 1985;103:861-872.
7. Sugar AM, Alsip SG, Galgiani JN, Graybill JR, Dismukes WE, Cloud GA, Craven PC, Stevens DA: Pharmacology' and toxicity of high dose ketoconazole. Antimicrob Agents Chemother 1987;31:1874-1878.
8. Stevens DA: Miconazole in the treatment of coccidioidomycosis. Drugs 1983;26:347-354.